Literature DB >> 20161343

Estimation and Comparison of Receiver Operating Characteristic Curves.

Margaret Pepe1, Gary Longton, Holly Janes.   

Abstract

The receiver operating characteristic (ROC) curve displays the capacity of a marker or diagnostic test to discriminate between two groups of subjects, cases versus controls. We present a comprehensive suite of Stata commands for performing ROC analysis. Non-parametric, semiparametric and parametric estimators are calculated. Comparisons between curves are based on the area or partial area under the ROC curve. Alternatively pointwise comparisons between ROC curves or inverse ROC curves can be made. Options to adjust these analyses for covariates, and to perform ROC regression are described in a companion article. We use a unified framework by representing the ROC curve as the distribution of the marker in cases after standardizing it to the control reference distribution.

Entities:  

Year:  2009        PMID: 20161343      PMCID: PMC2774909     

Source DB:  PubMed          Journal:  Stata J        ISSN: 1536-867X            Impact factor:   2.637


  11 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

2.  Partial AUC estimation and regression.

Authors:  Lori E Dodd; Margaret S Pepe
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

3.  Distribution-free ROC analysis using binary regression techniques.

Authors:  Todd A Alonzo; Margaret Sullivan Pepe
Journal:  Biostatistics       Date:  2002-09       Impact factor: 5.899

4.  The analysis of placement values for evaluating discriminatory measures.

Authors:  Margaret Sullivan Pepe; Tianxi Cai
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

5.  Standardizing diagnostic markers to evaluate and compare their performance.

Authors:  Margaret Sullivan Pepe; Gary Longton
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

6.  Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: an update.

Authors:  J A Hanley; K O Hajian-Tilaki
Journal:  Acad Radiol       Date:  1997-01       Impact factor: 3.173

7.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

8.  On the statistical analysis of ROC curves.

Authors:  M L Thompson; W Zucchini
Journal:  Stat Med       Date:  1989-10       Impact factor: 2.373

9.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

10.  Accommodating Covariates in ROC Analysis.

Authors:  Holly Janes; Gary Longton; Margaret Pepe
Journal:  Stata J       Date:  2009-01-01       Impact factor: 2.637

View more
  86 in total

1.  Estimating the diagnostic likelihood ratio of a continuous marker.

Authors:  Wen Gu; Margaret Sullivan Pepe
Journal:  Biostatistics       Date:  2010-07-16       Impact factor: 5.899

2.  Optical Coherence Tomography Angiography Compared With Optical Coherence Tomography Macular Measurements for Detection of Glaucoma.

Authors:  Kelvin H Wan; Alexander K N Lam; Christopher Kai-Shun Leung
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

3.  The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Authors:  Mikael Koskela; Elisa Ylinen; Elli-Maija Ukonmaanaho; Helena Autio-Harmainen; Päivi Heikkilä; Jouko Lohi; Outi Jauhola; Jaana Ronkainen; Timo Jahnukainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

Review 4.  The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.

Authors:  Hong-Gang Ren; Djamilatou Adom; Sophie Paczesny
Journal:  Expert Rev Clin Immunol       Date:  2018-04-19       Impact factor: 4.473

5.  2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?

Authors:  Stein J Janssen; Andrea S van der Heijden; Maarten van Dijke; John E Ready; Kevin A Raskin; Marco L Ferrone; Francis J Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2015-07-09       Impact factor: 4.176

6.  Prediction of Carotid Intraplaque Hemorrhage Using Adventitial Calcification and Plaque Thickness on CTA.

Authors:  L B Eisenmenger; B W Aldred; S-E Kim; G J Stoddard; A de Havenon; G S Treiman; D L Parker; J S McNally
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-21       Impact factor: 3.825

7.  Comparison of different spectral domain OCT scanning protocols for diagnosing preperimetric glaucoma.

Authors:  Renato Lisboa; Augusto Paranhos; Robert N Weinreb; Linda M Zangwill; Mauro T Leite; Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-13       Impact factor: 4.799

8.  A Comparison of OCT Parameters in Identifying Glaucoma Damage in Eyes Suspected of Having Glaucoma.

Authors:  Brian C Stagg; Felipe A Medeiros
Journal:  Ophthalmol Glaucoma       Date:  2019-11-27

9.  [Bruch's membrane opening minimum rim width : Correlation and diagnostic accuracy in comparison to peripapillary retinal nerve fiber layer thickness].

Authors:  M Awe; S Khalili-Amiri; I R Volkmann; B Junker; C Framme; K Hufendiek
Journal:  Ophthalmologe       Date:  2019-01       Impact factor: 1.059

10.  Magnetic Resonance Imaging and Clinical Factors Associated With Ischemic Stroke in Patients Suspected of Cervical Artery Dissection.

Authors:  J Scott McNally; Peter J Hinckley; Akihiko Sakata; Laura B Eisenmenger; Seong-Eun Kim; Adam H De Havenon; Edward P Quigley; Eli Iacob; Gerald S Treiman; Dennis L Parker
Journal:  Stroke       Date:  2018-10       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.